LABT

Lakewood-Amedex Biotherapeutics, Inc.

Sağlık

NON-COMPLIANT — One or more ratios exceed the threshold; the company is not compliant with halal investment criteria.

$0.34

Price (1 Year)

$73.5 $0.2

Participation Finance Screening Ratios

Non-compliant debt / Total market cap %12.9 / %30
Non-compliant assets / Total market cap %17.2 / %30
Non-compliant revenue / Total income %100 / %5

Ratios are taken from an AAOIFI-based screening file; this does not constitute a religious ruling.

About the Company

Lakewood-Amedex Biotherapeutics, Inc. operates as a clinical-stage biotechnology company that develops antimicrobial products in the United States. The company offers products from its Bisphosphocin class, a novel class of antimicrobial agents a broad range of infections, including those affecting the skin, bladder, and lungs.

Website

Analysis (Turkish): LABT Hissesi Caiz mi, Helal mi? Lakewood-Amedex Biotherapeutics, Inc. Katılım Analizi